Evaluation of sputum culture conversion as a prognostic marker for end-of-treatment outcome inpatients with multidrug-resistant tuberculosis

Kurbatova, Ekaterina V.; Cegielski, J. Peter; Lienhardt, Christian; Akksilp, Rattanawadee; Bayona, Jaime; Becerra, Mercedes C.; Caoili, Janice; Contreras, Carmen; Dalton, Tracy; Danilovits, Manfred; Demikhova, Olga V.; Ershova, Julia; Gammino, Victoria M.; Gelmanova, Irina; Heilig, Charles M.; Jou, Ruwen; Kazennyy, Boris; Keshavjee, Salmaan; Kim, Hee Jin; Kliiman, Kai; Kvasnovsky, Charlotte; Leimane, Vaira; Mitnick, Carole D.; Quelapio, Imelda; Riekstina, Vija; Smith, Sarah E.; Tupasi, Thelma; van der Walt, Martie; Vasilyeva, Irina A.; Via, Laura E.; Viiklepp, Piret; Volchenkov, Grigory; Walker, Allison Taylor; Wolfgang, Melanie; Yagui, Martin; Zignol, Matteo

doi:10.1016/S2213-2600(15)00036-3

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Evaluation of sputum culture conversion as a prognostic marker for end-of-treatment outcome inpatients with multidrug-resistant tuberculosis

3 2015
By Kurbatova, Ekaterina V. ; Cegielski, J. Peter ; Lienhardt, Christian ; ...
http://dx.doi.org/10.1016/S2213-2600(15)00036-3
Source: Lancet Respir Med. 2015; 3(3):201-209

[PDF-447.74 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Lancet Respir Med
Personal Author:

Kurbatova, Ekaterina V. ; Cegielski, J. Peter ; Lienhardt, Christian ; Akksilp, Rattanawadee ; Bayona, Jaime ; ... More +

Kurbatova, Ekaterina V. ; Cegielski, J. Peter ; Lienhardt, Christian ; Akksilp, Rattanawadee ; Bayona, Jaime ; Becerra, Mercedes C. ; Caoili, Janice ; Contreras, Carmen ; Dalton, Tracy ; Danilovits, Manfred ; Demikhova, Olga V. ; Ershova, Julia ; Gammino, Victoria M. ; Gelmanova, Irina ; Heilig, Charles M. ; Jou, Ruwen ; Kazennyy, Boris ; Keshavjee, Salmaan ; Kim, Hee Jin ; Kliiman, Kai ; Kvasnovsky, Charlotte ; Leimane, Vaira ; Mitnick, Carole D. ; Quelapio, Imelda ; Riekstina, Vija ; Smith, Sarah E. ; Tupasi, Thelma ; van der Walt, Martie ; Vasilyeva, Irina A. ; Via, Laura E. ; Viiklepp, Piret ; Volchenkov, Grigory ; Walker, Allison Taylor ; Wolfgang, Melanie ; Yagui, Martin ; Zignol, Matteo Less -
Description:

Background

To assess the validity of sputum culture conversion (SCC) on solid media at varying time points and the time to SCC as prognostic markers for end-of-treatment outcome in multidrug-resistant (MDR) tuberculosis (TB) patients.

Methods

Data on1,712 MDR-TB patients from two large cohort studies were analyzed. Measures of association were determined using random effects multivariable logistic regression. Predictive values were calculated using bivariate random-effects generalized linear mixed model.

Findings

Times to SCC and SCC status at 6 months were significantly associated with treatment success compared to failure or death. SCC status at 2 months was significantly associated with treatment success among patients without known HIV infection only. The overall association of SCC with a successful outcome was substantially stronger at 6 months (adjusted odds ratio [aOR]=14.07, 95% CI 10.05–19.71) than at 2 months (HIV-negative patients: aOR=4.12 [2.25–7.54]; HIV unknown: aOR=3.59 [1.96–6.58], HIV-positive: aOR=0.38 [0.12–1.18]). The 2-month SCC had low sensitivity (27%) and high specificity (90%) for predicting treatment success. Conversely, 6-month SCC status had high sensitivity (92%), but moderate specificity (58%). The maximum combined sensitivity and specificity for SCC was reached between the 6th and 10th month of treatment.

Interpretation

Time to SCC, SCC status at 6 months, and SCC status at 2 months among patients without known HIV infection can be considered proxy markers of end-of-treatment outcome in MDR-TB patients, but the overall association with treatment success is substantially stronger for 6-month compared to 2-month SCC.

Funding

USAID, the US CDC, the Division of Intramural Research of NIAID/NIH, and the Republic of Korea’s CDC.
Subjects:

[+]

Adolescent Adult Aged Humans Middle Aged Mycobacterium Tuberculosis Prospective Studies Sputum Treatment Outcome Tuberculosis, Multidrug-Resistant Tuberculosis, Pulmonary Young Adult
Keywords:

[+]

Multidrug-resistant Tuberculosis Outcome Prognostic Marker Sputum Culture Conversion Treatment
Source:

Lancet Respir Med. 2015; 3(3):201-209
Pubmed ID:

25726085
Pubmed Central ID:

PMC4401426
Document Type:

Journal Article
Funding:

001/WHO_/World Health OrganizationInternational/ ; CC999999/ImCDC/Intramural CDC HHSUnited States/ ; ImNIH/Intramural NIH HHSUnited States/

001/WHO_/World Health OrganizationInternational/ ; CC999999/ImCDC/Intramural CDC HHSUnited States/ ; ImNIH/Intramural NIH HHSUnited States/ Less -
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha256:deab06518eeed68375316c77c5792edc97ed83a09eaca4f0d35cf3d12c2d3331
Download URL:

https://stacks.cdc.gov/view/cdc/30521/cdc_30521_DS1.pdf
File Type:

	nihms671699f4.gif	gif
	nihms671699f4.jpg	jpeg
	NIHMS671699-supplement-01.pdf	pdf
	nihms671699.nxml	xml
	nihms671699f1.gif	gif
	nihms671699f1.jpg	jpeg
	nihms671699f2.gif	gif
	nihms671699f2.jpg	jpeg
	nihms671699f3.gif	gif
	nihms671699f3.jpg	jpeg

More +